The effective evaluation of contract research organization (CRO) clinical pathology and CRO anatomic pathology studies is pivotal to determining the safety and efficacy of developing pharmaceutical solutions. Leverage decades of experience in CRO Pathology services from AmplifyBio to receive comprehensive tissue collection and analysis of any study type. We have the ability to begin toxicological, safety pharmacological, and efficacy studies immediately, and can complete several at a time to meet your schedules. We continue to expand and invest in cutting-edge pathology technology and capacity to support you as the leader in commercially-driven studies that meet diverse goal sets.
AmplifyBio provides a wide range of capabilities that are built on experience and expertise for an extensive selection of pathological needs. Our professional pathologists can inform stakeholders with pivotal information within preclinical pathology and preclinical studies, pathology for in-vivo studies, and extensive expertise within the two core pathology types.
Capabilities include but are not limited to:
The platforms and technologies we utilize to enhance our capabilities continue to grow. Expanding CRO pathology capabilities we are currently investing further into, include:
Developing the gold standard for quantitative assessment of tissue morphometry.
Increasing our capacity for visual localization of compounds and expression variance in client target issues.
Unlocking opportunities in image analysis, remote collaboration, and data management.
Accelerating high throughput capacity in a regulated environment to meet client and timeline needs.
Talk with us about additional services on the horizon and more that we can provide through our collaborative network.
Learn more about what 75 + years of experience as a CRO pathological provider can do for you. From single studies to expanding capacity areas on the brink of innovation, AmplifyBio delivers flexible, timely pathological study solutions to meet your needs.